PD Med Collaborative Group

Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial

PD Med Collaborative Group, 2014, The Lancet.